Cyclopharm Limited Stock: price and insider trades · Australia
Cyclopharm Limited: what insiders have been doing
Cyclopharm Limited is a Health Care company. Its directors and officers file their transactions with ASX. Over the twelve months to 18 October 2026, 6 filings were filed, from 6 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Compared with its exchange (1,605 companies, median 4 filings), a count of 6 filings is above the norm.
There has been no open-market purchase by an insider of Cyclopharm Limited for at least a year.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. This summary is built from ASX disclosures alone and does not predict where the share price will go.
Analyst consensus: bullish or bearish?
Analysts rate Cyclopharm Limited Strong Buy (bullish), based on 1 analysts. Average price target: A$1.00.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- ShareASXISIN AU000000CYC5ASX:2924-03147064-2A1703463
- ShareASXASX:2924-03104024-2A1679458
- ShareASXISIN AU000000CYC5ASX:2924-03088317-2A1671244
- ShareASXISIN AU000000CYC5ASX:2924-03088315-2A1671243
- ●Unknown0ASXShareASXISIN AU000000CYC5ASX:2924-03086079-2A1669768
- ●Executives0ASX
6 of 6 declarations
About Cyclopharm Limited
Cyclopharm Limited is a company focused on the development and commercialization of radiopharmaceutical products. It is listed on the XASX market.
